Rho kinase inhibitors are a new class of glaucoma drugs currently in clinical trials. Rho kinase (dubbed “ROCK”) inhibitors promise to act specifically on the eye’s drainage canals (called the trabecular meshwork) a main outflow and blockage site in glaucoma.
Category: glaucoma
A recent study published findings that eating fruits and vegetables may help reduce the risk of glaucoma. The second leading cause of blindness in the world, glaucoma is a disease that damages the eye’s optic nerve.
iStent Prevents Advance of Glaucoma
As the second-leading cause of blindness worldwide, glaucoma is caused by increased pressure within the eye and typically causes no pain or symptoms in the first stages of the disease.
January is Glaucoma Awareness Month
Resolutions are usually on the top of everyone’s list come this time of year, but how many of you have included an annual eye exam on this list of things to accomplish?
NPR recently reported findings from a new study showing a correlation between oral contraceptives and the risk of glaucoma.
A new study from the Netherlands Ophthalmic Research Institute in Amsterdam shows women who experience early menopause may be at a higher risk of developing glaucoma later in life.